Skip to main content
SpringerLink
Log in

Cyclosporin A and skin disease

  • Chapter
Cyclosporin

Abstract

The treatment of skin diseases traditionally involves an empirical approach since neither the pathogenesis of the disease nor the mode of action of the treatments employed is well understood in most cases. In contrast the potential benefits of treating psoriasis with cyclosporin (CsA), a potent immunosuppressive drug widely used in organ transplantation because of its selective effect on T lymphocytes, were predicted because of the increasing evidence in support of psoriasis as a T cell-mediated disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Obalek, S., Haftek, M. and Glinski, W. (1977) Immunological studies in psoriasis. Dermatologien, 155, 13–23

    Article  CAS  Google Scholar 

  2. Krueger, G. G., Hill, H. R. and Jederberg, W. W. (1978) Inflammatory and immune cell function in psoriasis — a subtle disorder. I. In vivo and in vitro survey. J. Invest. Dermatol., 71, 189–194

    Article  PubMed  CAS  Google Scholar 

  3. Levantine, A. and Brostoff, J. (1975) Immunological responses of patients with psoriasis and the effect of treatment with methotrexate. Br. J. Dermatol., 93, 659–668

    Article  PubMed  CAS  Google Scholar 

  4. Guilhou, J.-J., Clot, J. and Meynadier, J. (1977) T cell defect in psoriasis: further studies on membrane markers and T cell functions from 60 patients. Arch. Dermatol Res., 260, 163–166

    Article  PubMed  CAS  Google Scholar 

  5. Goan, S.-R., Volk, H. D., Eichhorn, I. and Diezel, W. (1986) Differences in interferon-gamma response of psoriatic lymphocytes to stimulation with various mitogens. Biomed. Biochim. Ada, 45, 903–906

    CAS  Google Scholar 

  6. Baker, B. S., Swain, A. F., Valdimarsson, H. and Fry, L. (1984a) T-cell subpopulations in the blood and skin of patients with psoriasis. Br. J. Dermatol., 110, 37–44

    Article  PubMed  CAS  Google Scholar 

  7. Valdimarsson, H., Baker, B. S., Jonsdottir, I. and Fry, L. (1986) Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol. Today, 7, 256–259

    Article  Google Scholar 

  8. Bjerke, J. E., Krogh, H. K. and Matre, R. (1978) Characterisation of mononuclear cell infiltrate in psoriatic lesions. J. Invest. Dermatol., 71, 340–343

    Article  PubMed  CAS  Google Scholar 

  9. Bos, J. D., Bulsebosch, H. J., Krieg, S. R., Bakker, P. M. and Cormane, R. H. (1983) Immunocompetent cells in psoriasis: in situ immunophenotyping by monoclonal antibodies. Arch. Dermatol Res., 275, 181–189

    Article  PubMed  CAS  Google Scholar 

  10. Baker, B. S., Swain, A. F., Fry, L. and Valdimarsson, H. (1984) Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br. J. Dermatol., 110, 555–564

    Article  PubMed  CAS  Google Scholar 

  11. Baker, B. S., Swain, A. F., Griffiths, C. E. M., Leonard, J. N., Fry, L. and Valdimarsson, H. (1985) Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. Clin. Exp. Immunol., 61, 526–534

    PubMed  CAS  Google Scholar 

  12. Mackaness, G. B. (1969) The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J. Exp. Med., 129, 973–992

    Article  PubMed  CAS  Google Scholar 

  13. Horton, J. E., Raisz, L. G., Simmons, H. A., Oppenheim, J. J. and Mergenhagen, S. E. (1972) Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science, 177, 793–795

    Article  PubMed  CAS  Google Scholar 

  14. Korszum A.-K., Wilton, J. M. and Johnson, N. W. (1981) The in vivo effects of lymphokines on mitotic activity and keratinisation in guinea pig epidermis. J. Invest. Dermatol., 76, 433–437

    Article  Google Scholar 

  15. Whyte, H. J. and Baughman, R. D. (1964) Acute guttate psoriasis and streptococcal infection. Arch. Dermatol., 89, 350–356

    Article  PubMed  CAS  Google Scholar 

  16. Swerlick, R. A., Cunningham, M. W. and Hall, N. K. (1986) Monoclonal antibodies cross-reactive with Group A streptococci and normal and psoriatic human skin. J. Invest. Dermatol., 87, 367–371

    Article  PubMed  CAS  Google Scholar 

  17. Schopf, R. E., Hoffman, A., Jung, M. Morsches, B. and Bork, K. (1986) Stimulation of T cells by autologous mononuclear leukocytes and epidermal cells in psoriasis. Arch. Dermatol Res., 279, 89–94

    Article  PubMed  CAS  Google Scholar 

  18. Baker, B. S., Swain, A. F., Griffiths, C. E. M., Leonard, J. N., Fry, L. and Valdimarsson, H. (1985) The effects of topical treatment with steroids or dithranol on epidermal T lymphocytes and dendritic cells in psoriasis, Scand. J,. Immunol., 22, 471–477

    Article  CAS  Google Scholar 

  19. Griffiths, C.E. M., Fowles, A. V., Leonard, J. N., Baker, B. S., Valdimarsson, H. and Fry, L. (1986) Clearance of psoriasis with low dose cyclosporin. Br. Med. J., 293, 731–732

    Article  CAS  Google Scholar 

  20. Heule, F., Meinardi, M. M. H. M., van Joost, T. and Bos, J. D. (1988) Low-dose cyclosporine effective in severe psoriasis a double-blind study. Transplant Proc., 20, 32–41

    PubMed  CAS  Google Scholar 

  21. Palay, D. A., Cluff, C. W., Wentworth, P. A and Ziegler, H. K. (1986) Cyclosporine inhibits macrophage-mediated antigen presentation. J. Immunol., 136, 4348–4353

    PubMed  CAS  Google Scholar 

  22. Furue, M. and Katz, S. (1988) The effect of cyclosporine on epidermal cells. 1. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro. J. Immunol., 140, 4139–4143

    CAS  Google Scholar 

  23. Lu, C. Y., Lemay, P. A. and Lombardi, M. J. (1988) Inhibition of antigen-specific activation of an L3T4+ T cell line by cyclosporine with maintenance of macrophage-mediated antigen-presentation. Transplantation, 45, 187–193

    Article  PubMed  CAS  Google Scholar 

  24. Bunjes, D., Hardt, C., Rollinghoff, M. and Wagner, H. (1981) Cyclosporine A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interieukin 2. Eur. J. Immunol., 11, 657–661

    Article  PubMed  CAS  Google Scholar 

  25. Granelli-Piperno, A., Inaba, A. K. and Steinman, R. M. (1984) Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. J. Exp. Med., 160, 1792–1802

    Article  PubMed  CAS  Google Scholar 

  26. Reem, G. H., Cook, L. A. and Vilcek, J. (1983) Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science, 221, 63–65

    Article  PubMed  CAS  Google Scholar 

  27. Lafferty, K. J., Borel, J. F. and Hodskin, P. (1983) Cyclosporine-A (CS): models for the mechanism of action. Transplant. Proc., 15, 2242–2247

    CAS  Google Scholar 

  28. Thomson, A. W., Moon, D. K., Geczy, C. L. and Nelson, D. S. (1983) Cyclosporin A inhibits lymphokine production but not the response of macrophages to lymphokines. Immunology, 48, 291–299

    PubMed  CAS  Google Scholar 

  29. Kupiec-Weglinski, J. W., Filho, M. A., Strom, T. B. and Tilney, N. L. (1984) Sparing of suppressor cells: a critical action of cyclosporine. Transplantation, 38, 97–101

    Article  PubMed  CAS  Google Scholar 

  30. Klaus, G. G. B. and Hawrylowicz, G M. (1984) Activation and proliferation signals in mouse B cells. II. Evidence for activation (G0 to G1) signals differing in sensitivity to cyclosporine. Eur. J. Immunol., 14, 250–254

    Article  PubMed  CAS  Google Scholar 

  31. Berrjdge, M. J. and Irvine, R. F. (1984) Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature, 312, 315–321

    Article  Google Scholar 

  32. Rosoff, P. M. and Cantley, L. C. (1985) Stimulation of the T3-T cell receptor-associated Ca++ influx enhances the activity of the Na+/H+ exchanger in a leukaemic human T cell line. J. Biol Chem., 260, 14053–14059

    PubMed  CAS  Google Scholar 

  33. Kroggel, R., Goppett-Strube, M., Martin, M. and Resch, K. (1987) The immunosuppressive activities of different cyclosporins are correlated to inhibition of the early membrane phospholipid metabolism in activated lymphocytes. Immunobiology, 175, 159–171

    PubMed  CAS  Google Scholar 

  34. Metcalfe, S. (1984) Cyclosporine does not prevent cytoplasmic calcium changes associated with lymphocyte activation. Transplantation, 38, 161–164

    Article  PubMed  CAS  Google Scholar 

  35. Wiskodl R., Weiss, A., Imboden, J., Kamin-Lewis, R. and Stobo, J. (1985) Activation of a human T cell line: a 2 stimulus requirement in the pretranslational events involved in the coordinate expression of IL-2 and gamma-Interferon genes. J. Immunol., 134, 1599–1603

    Google Scholar 

  36. Rosoff, P. and Teres, G. (1986) Cyclosporin inhibits Ca++ dependent stimulation of Na+/H+ antiport In human T cells. J. Cell Biol., 103, 457–463

    Article  PubMed  CAS  Google Scholar 

  37. Merker, M. M. and Hanschumacher, R. E. (1984) Uptake and nature of the intracellular binding of cyclosporine A in a murine thymoma cell line, BW 5147. J. Immunol., 132, 3064–3070

    PubMed  CAS  Google Scholar 

  38. Larson, D. F. (1986) Larson, D. F. (1986) Mechanism of action: antagonism of the prolactin receptor. Progr. Allergy, 38, 222–238

    CAS  Google Scholar 

  39. Colombani, P. M., Robb, A. and Hess, A. D. (1985) Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes Science, 228, 337–339

    Article  PubMed  CAS  Google Scholar 

  40. Legrue, S. J., Turner, R., Weisbrodt, N. and Dedman, J. R. (1986) Does the binding of cyclosporine to calmodulin result in immunosuppression? Science, 234, 68–71

    Article  PubMed  CAS  Google Scholar 

  41. Hanschumacher, R. E., Harding, M. W., Rice, J. and Drugge, R. J. (1984) Cyclophilin: a specific cytosolic binding protein for cyclosporin A Science, 226, 544–547

    Article  Google Scholar 

  42. Klaus, G. G. B. and Kunkle, A. (1983) Effects of cyclosporin on the immune system of the mouse. Transplantation, 36, 80–84

    Article  PubMed  CAS  Google Scholar 

  43. Kunkle, A. and Klaus, G. G. B. (1980) Selective effects of cyclosporin A on functional B cell subsets in the mouse. J. Immunol., 125, 2526–2531

    Google Scholar 

  44. Shevach, E. M. (1985) The effects of cyclosporin A on the immune system. Ann. Rev. Immunol., 3, 397–423

    Article  CAS  Google Scholar 

  45. Borel, J. F., Feurer, C., Gibner, H. U. and Stahelein, N (1976) Biological effects of cyclosporin A: a new antiiymphocytic agent. Agents Actions, 6, 468–475

    Article  PubMed  CAS  Google Scholar 

  46. Meuller, W. and Hermann, B. (1979) Cyclosporin A for psoriasis. N. Engl. J. Med., 301, 555

    Google Scholar 

  47. Gubner, R., August, S. and Gincberg, V. (1951) Therapeutic suppression of tissue reactivity. IL Effect of aminopterine In rheumatoid arthritis and psoriasis.Ann. J. Med. Sci., 221, 688–699

    Google Scholar 

  48. Harper, J. I., Keat, A. C. S. and Staughton, R. C. D. (1984) Cyclosporin for psoriasis. Lancet, 2, 981–982

    Article  PubMed  CAS  Google Scholar 

  49. Van Hooff, J. P., Leunissen, K. M. L. and Staak, W. V. D. (1985) Cyclosporin for psoriasis. Lancet, 1, 335

    Article  PubMed  Google Scholar 

  50. Van Joost, T. H., Heule, F., Stolz, E. and Beukers, R. (1986) Short-term use of cyclosporin A in severe psoriasis. Br. J. Dermatol., 114, 615–620

    Article  PubMed  Google Scholar 

  51. Marks, J. M. (1986) Cyclosporin A treatment of severe psoriasis. Br. J. Dermatol., 115, 745–746

    Article  PubMed  CAS  Google Scholar 

  52. Ellis, C. N., Gorsulowsky, D. C., Hamilton, T. A., Billings, J. K., Brown, M. D., Headington, J. T., Cooper, K. D., Baadsgard, O., Duell, E. A., Aruiesley, T. M., Turcotte, J. G. and Vorhees, J. J. (1986) Cyclosporine improves psoriasis in a double-blind study. J. Am. Med. Assoc., 256, 3110–3116

    Article  CAS  Google Scholar 

  53. Wentzell, J. M., Baughman, R. W., O’Connor, G. T. and Bernier, G. M. (1987) Cyclosporine in the treatment of psoriasis. Arch. Dermatol., 123, 163–165

    Article  PubMed  CAS  Google Scholar 

  54. Picascia, D. D., Garden, J. M., Freinkel, R. K. and Roenigk, H. H. (1987) Treatment of resistant severe psoriasis with systemic cyclosporine. J. Am. Acad. Dermatol., 17, 408–414

    Article  PubMed  CAS  Google Scholar 

  55. Griffiths, C E. M., Powles, A. V., McFadden, J. P., Baker, B. S., Valdimarsson, H. and Fry, L. (1989) Long-term cyclosporin for psoriasis. Br. J. Dermatol, 120, 253–260

    Article  PubMed  CAS  Google Scholar 

  56. Fredriksson, T. and Petterson, V. (1978) Severe psoriasis oral therapy with a new retinoid. Dermatohgica, 157, 238–244

    Article  CAS  Google Scholar 

  57. Calne, R. Y., White, D. J. G. and Thiru, S. (1978) Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet, 2, 1323–1327

    Article  PubMed  CAS  Google Scholar 

  58. Tegzess, A M. (1988) Ciclosporin and renal function. In van Joost, T. H. and Heule, F., Bos, J. D. (eds), Ciclosporin (Sandimmune) in Psoriasis, (Uden: Sandoz), pp. 128–136

    Google Scholar 

  59. Schauder, C S. and Gorulowsky, D. C. (1986) Topical cyclosporine A in the treatment of psoriasis. Clin. Res., 34, 1007A

    Google Scholar 

  60. Griffiths, C E. M., Powles, A. V., Baker, B. S., Fry, L. and Valdimarsson, H. (1987) Topical cyclosporin and psoriasis. Lancet, 1, 806

    Article  PubMed  CAS  Google Scholar 

  61. Schulze, H. J., Mahrle, G. and Steigleder, G. K. (1988) Topical application of ciclosporin in psoriasis. In van Joost, Th., Heule, F. and Bos, J. D. (eds), Ciclosporin (Sandimmune) in Psoriasis (Lden: Sandoz), pp. 102–104

    Google Scholar 

  62. Aldridge, R. W., Sewell, H. F., King, G. and Thomson, A. W. (1986) Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical immunohistochemical investigation. Clin. Exp. Immunol., 66, 582–589

    PubMed  CAS  Google Scholar 

  63. Parodi, A. and Rebora, A. (1987) Topical cyclosporine in alopecia areata. Arch. Dermatol., 123, 165

    Article  PubMed  CAS  Google Scholar 

  64. Thomson, A. W., Aldridge, R. D. and Sewell, H. F. (1986) Topical cyclosporin in alopecia areata and nickel contact dermatitis. Lancet, 21, 971–972

    Article  Google Scholar 

  65. Aldridge, R. A., Thomson, A. W., Rankin, R., Whiting, P. H., Cunningham, C. and Simpson, J. G. (1985) Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea pig. Clin. Exp. Immunol., 59, 23–28

    PubMed  CAS  Google Scholar 

  66. Powles, A. V., Baker, B. S., McFadden, J. P., Rutman, A., Griffiths, C. E. M. and Fry, L. (1988) Intralesional injection of cyclosporin in psoriasis. Lancet, 1, 537

    Article  PubMed  CAS  Google Scholar 

  67. Van Joost, T. H., Stolz, E. and Heule, F. (1987) Efficacy of low dose cyclosporine in severe atopic skin disease. Arch. Dermatol., 123, 166–167

    Article  PubMed  Google Scholar 

  68. Camp, R. D. R. and Logan, R. A. (1987) Cyclosporine in atopic dermatitis. In The Second International Congress of Cyclosporine. (Texas; The University of Texas Health Science Centre). Abstracts, p. 51

    Google Scholar 

  69. Jensen, J. R., Thestrup-Pedersen, K., Zachariae, H. and Sogaard, H. (1987) Cyclosporin A for therapy for mycosis fungoides. Arch Dermatol., 123, 160–163

    Article  PubMed  CAS  Google Scholar 

  70. Thomson, K. and Wantzin, G. L. (1987) Extracutaneous spreading with fatal outcome of mycosos fungoides in a patient treated with ciclosporin A. Dermatologica, 174, 236–238

    Article  Google Scholar 

  71. Catterall, M. D., Addis, B. J. and Smith, J. L. (1983) Sezary syndrome: transformation to a high lymphoma after treatment with cyclosporine A. Clin. Exp. Dermatol., 8, 159

    Article  PubMed  CAS  Google Scholar 

  72. Puttick, L., Pollack, A. and Fairburn, E. (1983) Treatment of Sezary syndrome with cyclosporine A. J. R. Soc. Med., 76, 1063–1065

    PubMed  CAS  Google Scholar 

  73. Moreland, A. A., Robertson, W. B. and Heffner, L. T. (1985) Treatment of cutaneous T cell lymphoma with cyclosporin. J. Am. Acad. Dermatol., 12, 886-887

    Article  PubMed  CAS  Google Scholar 

  74. Totterman, T. H., Scheynius, A., Killander, A., Danersuna, A. and Alm, G. V. (1985) Treatment of therapy-resistant Sezary syndrome with cyclosporine A. Scand. J. Haematol., 34, 196–203

    Article  PubMed  CAS  Google Scholar 

  75. Barthelemy, H., Biron, F., Claudy, A., Souterland, P. and Thivolet, J. (1986) Cyclosporine: a new immunosuppressive agent in bullous pemphigoid and pemphigus. Transplant. Proc., 18, 913–914

    Google Scholar 

  76. Cunliffe, W. J. (1987) Pemphigus foliaceus and response to cyclosporin. Br. J. Dermatol., 117 (Suppl. 32), 114–116

    Article  Google Scholar 

  77. Balda, B. R. and Rosenzweig, D. (1985) Treatment of bullous dermatoses with cyclosporin. In Schindler, R. (ed.), Ciclosporin in Autoimmune Diseases. (Berlin: Springer), pp. 209–214

    Google Scholar 

  78. de Prost, Y., Teillac, D., Paquez, F., Carrugi, C., Bachelez, H. and Touraine, R. (1988) Treatment of severe alopecia areata by topical applications of cyclosporine. Transplant. Proc., 20 (Suppl. 4), 112–113

    PubMed  Google Scholar 

  79. Mauduit, G., Lenvers, P., Barthelemy, H. and Thivolet, J. (1987) Treatment of alopecia areata with topically applied cyclosporin A. Ann. Dermatol Venereol., 114, 507–510

    PubMed  CAS  Google Scholar 

  80. Gupta, A. K., Ellis, C. N., Tellner, D. C. and Voorhees, J. J. (1988) Cyclosporine A in the treatment of severe alopecia areata. Transplant Proc., 20 (Suppl. 4), 105–108

    PubMed  CAS  Google Scholar 

  81. Lucia, M. G., Woan, M. C., Scheizer, R. T., Koscioi, C. M., Johnson, R. L. and Sharpe, R. J. (1986) Cyclosporine inhibits the proliferation of squamous cells. Fed. Proc., 45, 272

    Google Scholar 

  82. Katp, N., Halprin, K. M. and Taylor, J. R. (1987) Cyclosporin A does not inhibit epidermal cell growth at therapeutic levels. J. Invest. Dermatol., 88, 52–54

    Google Scholar 

  83. Kelly, G. E., Sheil, A. G. R., Wass, J. and Zbroja, R. A. (1986) Effects of ultraviolet radiation and immunosuppressive therapy on mouse epidermal cell kinetics. Br. J. Dermatol., 114, 197–208

    Article  PubMed  CAS  Google Scholar 

  84. Fisher, G. J., Duell, E. A., Nickoloff, B. J., Annesley, T. M., Kowalke, J. K., Ellis, C. N. and Vorjees, J. J. (1988) Levels of cyclosporin in epidermis of treated psoriasis patients differentially inibit growth of keratinocytes cultured in serum free versus serum containing media. J. Invest Dermatol., 91, 142–146

    Article  PubMed  CAS  Google Scholar 

  85. Saiag, P., Coulomb, B., Lebreton, C., Bell, E. and Dubertret, L. (1985) Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science, 230, 669–672

    Article  PubMed  CAS  Google Scholar 

  86. Nickoloff, B. J., Fisher, G. J., Mitra, R. S. and Vorhees, J. J. (1988) Direct cytopathic effects of cyclosporin A on rapidly proliferating cultured keratinocytes and dermal fibroblasts. Transplant. Proc., 20, 85–90

    PubMed  CAS  Google Scholar 

  87. Baker, B. S., Griffiths, C. E. M., Lambert, S., Powles, A. V., Leonard, J. N., Valdimarsson, H. and Fry, L. (1987) The effects of cyclosporin A on T lymphocyte and dendritic cell subpopulations in psoriasis. Br. J. Dermatol., 116, 503–510

    Article  PubMed  CAS  Google Scholar 

  88. Sauder, D. N., Monick, M. M. and Hunninghake, G. W. (1985) Epidermal cell-derived thymocyte activating factor (ETAF) is a potent T-cell chemoattractant. J. Invest. Dermatol., 85, 431–433

    Article  PubMed  CAS  Google Scholar 

  89. Ali, A. T. M. M., Morley, J. and Rumjanek, V. M. (1982) Inhibition of lymphocyte accumulation by cyclosporin A. Br. J. Pharmacol., 75, 126P

    Google Scholar 

  90. Griffiths, C E. M, Powies, A. V., Baker, B. S., Fry, L. and Valdimarsson, H. (1987) Combination of cyclosporine A and topical corticosteroid in the treatment of psoriasis. Transplant Proc., 20, 50–52

    Google Scholar 

  91. Whisler, R. L., Lindsey, J. A., Proctor, K. V. W., Newhouse, Y G. and Cornwell, D. G, (1985) The impaired ability of human monocytes to stimulate autologous and allogeneic mixed lymphocyte reactions after exposure to cyclosporin. Transplantation, 40, 57–61

    Article  PubMed  CAS  Google Scholar 

  92. Baker, B. S., Powles, A. V., Savage, C. R., McFadden, J. P., Valdimarsson, H. and Fry, L. (1988) Intralesional cyclosporin A in psoriasis: effects on T lymphocyte and dendritic cell subpopulations. Br. J. Dermatol. (In press)

    Google Scholar 

  93. Buurman, W. A., Daeman, A. J. J. M., van der Linden, C. J. and Kootstra, G. (1987) Clinically used concentrations of cyclosporin A only partially inhibit interferon-gamma production by activated T lymphocytes. Transplantation, 19, 1193

    CAS  Google Scholar 

  94. Berman, B., Duncan, M. R.,Smith, B., Ziboh, V. A. and Palladino, M. (1985) Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells. J. Invest. Dermatol., 84, 54–58

    Article  PubMed  CAS  Google Scholar 

  95. Fan, T.-P. D. and Lewis, G. P. (1985) Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophages. Prostaglandins, 30, 735–747

    Article  PubMed  CAS  Google Scholar 

  96. Tucker, W. F. G., MacNeil, S., Bleehan, S. S. and Tomlinson, S. (1984) Biologically active calmodulin levels are elevated in both involved and uninvolved epidermis in psoriasis. J. Invest. Dermatol., 82, 298–299

    Article  PubMed  CAS  Google Scholar 

  97. Iizuka, H., Hashimoto, Y., Hirokawa, M., Matsuo, S., Mizumoto, T. and Ohkawara, A. (1985) Pig-skin epidermal calmodulin: effects of antagonists of calmodulin on DNA-synthesis of pig-skin epidermis. Arch. Dermatol Res., 278, 133–157

    Article  PubMed  CAS  Google Scholar 

  98. Tucker, W. F. G., MacNeil, S., Dawson, R. A., Tomlinson, S. and Bleehan, S. S. (1986) An investigation of the ability of anti-psoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin). J. Invest. Dermatol., 87, 232–235

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Anne V. Powles
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara S. Baker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lionel Fry
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Immunopathology Laboratory, Department of Pathology, University of Aberdeen, Foresterhill, Aberdeen, AB9 2ZD, Scotland

    Angus W. Thomson BSc(Hons), MSc, PhD, DSc, MRCPath, FIBiol (Reader in Immunology) (Reader in Immunology)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Powles, A.V., Baker, B.S., Fry, L. (1989). Cyclosporin A and skin disease. In: Thomson, A.W. (eds) Cyclosporin. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0859-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0859-8_10

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6874-1

  • Online ISBN: 978-94-009-0859-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation